EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Breast and cervical cancer in transgender men: literature review and a case report

Francesca Sofia Di Lisa, Alice Villa, Lorena Filomeno iD, Teresa Arcuri, Benito Chiofalo, Giuseppe Sanguineti, Laura Pizzuti, Eriseld Krasniqi, Maddalena Barba iD, Domenico Sergi, Francesco Lombardo, Francesco Romanelli und 4 weitere

Therapeutic Advances in Medical Oncology · 2024-01 · 16

DOI: 10.1177/17588359241259466 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Therapeutic Advances in Medical Oncology, online erschienen am 10.08.2024. Verfasst von Francesca Sofia Di Lisa und 15 weiteren Autor:innen. Beteiligte Einrichtung: Phase IV Clinical Studies Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ricerca Corrente granted by the Italian Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transgender individuals exhibit a higher prevalence of cancer-related risk factors, such as substance abuse and sexually transmitted infections. These factors, coupled with suboptimal adherence to cancer screening recommendations, may lead to a higher incidence of cancers, such as breast and cervical cancer, and contribute to delayed diagnoses in transgender patients. Herein, we report a unique case of a transgender man with a history of alcohol and drug abuse, undergoing gender-affirming exogenous testosterone therapy, who developed synchronous locally advanced breast cancer and human papilloma virus (HPV)-related cervical cancer. He underwent concurrent chemoradiation for cervical cancer and surgery followed by endocrine therapy for breast cancer. The treatments were suboptimals due to patient’s comorbidities, among them liver cirrhosis leading to an early death. Additionally, we have conducted a review of existing literature, including case reports, clinical studies, and review articles investigating the role of potential risk factors specifically related to breast and cervical tumors in transgender men. Gender-affirming testosterone therapy is common among transgender men to induce gender affirmation, but its link to breast cancer risk remains ambiguous, with studies being limited and sometimes contradictory. Conversely, HPV is a well-established cause of up to 99% of cervical cancers. Despite persistent risk for cervical cancer in transgender men who retain their cervix, several studies indicate notable disparities in screening adherence, due to personal and structural barriers. Moreover, alcohol and drug use disorders, commonly encountered in transgender population, may negatively influence the adherence to screening programs. Current cancer screening guidelines for this population are somewhat unclear, and specific programs based on more robust data are urgently required along with further tailored studies.

Schlagwörter

Stichwörter der Autor:innen

breast and cervical cancercase reportscreeningtestosterone therapytransgender men

Autor:innen und Institutionen

  • Phase IV Clinical Studies Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
  • Phase IV Clinical Studies Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, Rome 00144, Italy.
  • Medical Oncology A, Policlinico Umberto I, Department of Radiological, Oncological and Anatomo-Pathological Sciences, Sapienza University of Rome, Rome, Italy.
  • Gynecologic Oncology Unit, Department of Experimental Clinical Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Department of Radiation Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

ORCID-Profile: Lorena Filomeno, Maddalena Barba

Förderung

  • Ricerca Corrente granted by the Italian Ministry of Health

Zitieren

APA

Di Lisa, F. S., Villa, A., Filomeno, L., Arcuri, T., Chiofalo, B., Sanguineti, G., Pizzuti, L., Krasniqi, E., Barba, M., Sergi, D., Lombardo, F., Romanelli, F., Botti, C., Zoccali, G., Ciliberto, G., & Vici, P. (2024). Breast and cervical cancer in transgender men: literature review and a case report. Therapeutic Advances in Medical Oncology, 16. https://doi.org/10.1177/17588359241259466

Vancouver

Di Lisa FS, Villa A, Filomeno L, Arcuri T, Chiofalo B, Sanguineti G, et al. Breast and cervical cancer in transgender men: literature review and a case report. Therapeutic Advances in Medical Oncology. 2024;16. doi:10.1177/17588359241259466

BibTeX
@article{DiLisa2024,
  author = {Di Lisa, Francesca Sofia and Villa, Alice and Filomeno, Lorena and Arcuri, Teresa and Chiofalo, Benito and Sanguineti, Giuseppe and Pizzuti, Laura and Krasniqi, Eriseld and Barba, Maddalena and Sergi, Domenico and Lombardo, Francesco and Romanelli, Francesco and Botti, Claudio and Zoccali, Giovanni and Ciliberto, Gennaro and Vici, Patrizia},
  title = {Breast and cervical cancer in transgender men: literature review and a case report},
  journal = {Therapeutic Advances in Medical Oncology},
  year = {2024},
  volume = {16},
  doi = {10.1177/17588359241259466}
}
Kostenlos starten →